Ultrasound-Guided Erector Spinae Plane Block Versus Oblique Subcostal Transversus Abdominis Plane Block in Laparoscopic Cholecystectomy

Helwan University

Status

Completed

Conditions

Erector Spinae Plane Block

Oblique Subcostal Transversus Abdominis Plane Block

Laparoscopic Cholecystectomy

Ultrasound

Treatments

Other: Erector spinae plane block

Other: Oblique subcostal transversus abdominis plane block

Study type

Interventional

Funder types

Other

Identifiers

NCT06640062

118-2022

Details and patient eligibility

About

The aim of this work was to compare the effect of using oblique subcostal transversus abdominis plane (OSTAP) block and erector spinae plane (ESP) block as a part of multi-modal analgesia technique in patients undergoing laparoscopic cholecystectomy.

Full description

Laparoscopic cholecystectomy is a commonly performed surgery and requires multi-modal analgesia for better control of pain. Untreated post-operative pain has many consequences, including patient dissatisfaction, transition into chronic pain, delayed discharge from the hospital, and increased healthcare costs.

Many inter-fascial plane blocks like oblique subcostal transversus abdominis plane (OSTAP) block and recently, erector spinae plane (ESP) block have been utilized as a part of multi modal analgesia technique in many abdominal surgeries.

Enrollment

50 patients

Sex

All

Ages

20 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Age from 20 to 60 years.
Both gender.
American Society of Anesthesiologists (ASA) grade I and II physical status.
Body mass index (BMI): ≥ 20 kg/m2 and ≤ 35 kg/m2.
Underwent laparoscopic cholecystectomy.

Exclusion criteria

Patient refusal.
Known sensitivity or contraindication to drugs used in the study (local anesthetics, opioids).
History of psychological disorders and/or chronic pain syndrome.
Contraindication to regional anesthesia, e.g., local sepsis, pre-existing peripheral neuropathies, and coagulopathy.
Severe respiratory disorders such as (severe obstructive pulmonary disease, forced expiratory volume (FEV1), forced vital capacity (FVC) <50% or severe restrictive pulmonary disease, and adult respiratory distress syndrome).
Severe cardiac disorders such as (heart failure).
Advanced liver disease (elevated liver enzymes more than 3 folds of normal range).
Advanced kidney disease (Decreased creatinine clearance <40 ml/min).
Pregnancy.